Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Indian Journal of Hematology and Blood Transfusion
Erschienen in: Indian Journal of Hematology and Blood Transfusion 3/2022

10.01.2022 | Review Article

Reinduction of the Temporarily Deferred Donors for Laying the Foundation of Safe and Sustainable Blood Supplies: A Review in the Indian Context

verfasst von: Priyadarsini Jayachandran Arcot, Karan Kumar, Suchet Sachdev, Ratti Ram Sharma, Poonam Coshic

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Temporarily deferred donors are a forgotten pool of potential blood source. When dealt appropriately, they can easily be inducted back to the main stream pool of voluntary donors. Although there are multiple studies from India on the deferral rates and patterns; not much has been done with respect to the follow up of these donors and active efforts to bring them back to donate blood. In this narrative review, we discuss the impact of temporary deferral, factors affecting the return and appropriate strategies to improve the return rate of these donors.
Literatur
1.
Gillespie TW, Hillyer CD (2002) Blood donors and factors impacting the blood donation decision. Transfus Med Rev 16:115–130PubMedCrossRef
2.
Mishra SK, Sachdev S, Marwaha N et al (2016) Study of knowledge and attitude among college-going students toward voluntary blood donation from north India. J Blood Med 7:19–26PubMedPubMedCentral
3.
Ferguson E (2021) Strategies and theories to attract and retain blood donors: fairness, reciprocity, equity and warm-glow. ISBT Sci Ser 16:219–225CrossRef
4.
Das K, Geetanjali, Sachdev S et al (2014) Knowledge, attitude and practices of blood donors toward blood donation. J Postgrad Med Edu Res 48:123–127CrossRef
5.
Yuan S, Hoffman M, Lu Q et al (2011) Motivating factor and deterrents for blood donation among donors at a university campus-based collection centre. Transfusion 51:2438–2444PubMedCrossRef
6.
Sadler A, Shi L, Bethge S et al (2018) Incentives for blood donation: a discrete choice experiment to analyze extrinsic motivation. Transfus Med Hemother 45:116–124PubMedPubMedCentralCrossRef
7.
Senaldi E (2019) Donor recruitment: motivate their hearts. Ann Blood 4:19CrossRef
8.
Mohammed S, Essel HB (2018) Motivational factors for blood donation, potential barriers, and knowledge about blood donation in first-time and repeat blood donors. BMC Hematol 18:36PubMedPubMedCentralCrossRef
9.
10.
Sharma RR, Lozano M, Fearon M et al (2017) Vox sanguinis International Forum on donor notification and counselling strategies for markers of transfusion-transmissible infections. Vox Sang 112:e1–e21PubMedCrossRef
11.
Sharma RR, Lozano M, Fearon M et al (2017) Vox sanguinis international forum on donor notification and counselling strategies for markers of transfusion-transmissible infections: summary. Vox Sang 112:388–396PubMedCrossRef
12.
Bhasker B, Sachdev S, Marwaha N et al (2018) Knowledge and attitude regarding hepatitis B and C among blood donors and nondonors in North India. J Clin Hepatol 9:318–323CrossRef
13.
Prakash C, Sachdev S, Marwaha N et al (2019) Prevalence of Hepatitis B and C viral markers in blood donors deferred from donating blood on the basis of a history of jaundice of unknown origin. J Clin Exp Hepatol 9:156–161PubMedCrossRef
14.
Hillgrove T, Moore V, Doherty K et al (2011) The impact of temporary deferral due to low hemoglobin: future return, time to return, and frequency of subsequent donation. Transfusion 51:539–547PubMedCrossRef
15.
Halperin D, Baetens J, Newman B (1998) The effect of short-term, temporary deferral on future blood donation. Transfusion 38:181–183PubMedCrossRef
16.
Spekman MLC, Van Tilburg TG, Merz EM (2019) Do deferred donors continue their donations? A large-scale register study on whole blood donor return in the Netherlands. Transfusion 59:3657–3665PubMedPubMedCentralCrossRef
17.
Custer B, Chinn A, Hirschler NV et al (2007) The consequences of temporary deferral on future whole blood donation. Transfusion 47:1514PubMedCrossRef
18.
19.
Kandasamy D, Shastry S, Chenna D et al (2020) Blood donor deferral analysis in relation to the screening process: a single-center study from Southern India with emphasis on High Hemoglobin Prevalence. J Blood Med 11:327–334PubMedPubMedCentralCrossRef
20.
Sundar P, Sangeetha SK, Seema DM et al (2010) Pre-donation deferral of blood donors in South Indian set-up: an analysis. Asian J Transfus Sci 4:112–115PubMedPubMedCentralCrossRef
21.
22.
Chauhan C, Chauhan R, Awasthi S et al (2018) Pattern and outcome of donor deferral-? Need of hour. Int J Res Med Sci 6:289–292CrossRef
23.
Meinia SK, Sawhney V (2016) Analysis of donor deferral rate and its various causes in voluntary and replacement blood donors in Jammu, India. Int J Health Sci Res 6:49–56
24.
John F, Varkey MR (2015) Evaluation of blood donor deferral causes in a tertiary hospital, South India. Int J BioMed Adv Res 6:253–258CrossRef
25.
Chaudhary RK, Gupta D, Gupta RK (1995) Analysis of donor-deferral pattern in a voluntary donor population. Transfus Med 5:209–212PubMedCrossRef
26.
Bahadur S, Jain S, Goel RK et al (2009) Analysis of blood donor deferral characteristics in Delhi, India. Southeast Asian J Trop Med Public Health 40:1087–1091PubMed
27.
Shah R, Tulsiani S, Harimoorthy V et al (2013) Analysis of efforts to maintain safe donor in main donor pool after completion of temporary deferral period. Asian J Transfus Sci 7:63–67PubMedPubMedCentralCrossRef
28.
Mulla FI, Inaniya KS (2017) Assessment of donor return following temporary deferral (in camp as well as in-house donors) in a blood bank attached to tertiary care hospital. Int J Res Med Sci 5:1846–1850CrossRef
29.
Alok K, Satyendra P, Sharma SM et al (2014) Impact of counseling on temporarily deferred donor in a tertiary care hospital, central India: a prospective study. Int J Med Public Health 4:400–403CrossRef
30.
Hillgrove TL, Doherty KV, Moore VM (2012) Understanding non-return after a temporary deferral from giving blood: a qualitative study. BMC Public Health 12:1063PubMedPubMedCentralCrossRef
31.
Zou S, Musavi F, Notari EP et al (2008) Donor deferral and resulting donor loss at the American Red Cross Blood services, 2001 through 2006. Transfusion 48:2531–2539PubMedCrossRef
32.
Custer B, Schlumpf KS, Wright D et al (2011) Donor return after temporary deferral. Transfusion 51:1188–1196PubMedCrossRef
33.
Tanya ED, Masser BM, Gemeli CN (2020) Deferred and deterred: a review of literature on the impact of deferrals on blood donors. ISBT Sci Ser 15:3–10
34.
Eder A, Goldman M, Rossman S et al (2009) Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev 23:205–220PubMedCrossRef
35.
Delage G, Myhal G, Gregoire Y et al (2014) Donor’s psychological reactions to deferral following false-positive screening test results. Vox Sang 107:132–139PubMedCrossRef
36.
Hoogerwerf MD, Veldhuizen IJT, van den Hurk K et al (2016) Negative experiences and predonation blood pressure at the subsequent donation in blood donors. Vox Sang 110:107–115PubMedCrossRef
37.
Din SAT, Moze T, Karim FA et al (2020) Factors affecting the return of first-time blood donors after temporary deferral. J of Biomed & Clin Sci 5:42–48
38.
Sachdev S, Mittal K, Patidar G et al (2015) Risk factors for transfusion transmissible infections elicited on post donation counselling in blood donors: Need to strengthen pre-donation counselling. Indian J Hematol Blood Transfus 31:378–384PubMedCrossRef
39.
Bruhin A, Goette L, Haenni S et al (2020) The sting of rejection: Deferring blood donors due to low hemoglobin values reduces future returns. Transfus Med Hemother 47:119–128PubMedCrossRef
40.
Malako D, Yoseph F, Bekele ML (2019) Assessment of knowledge, attitude and practice and associated factors of blood donation among health care workers in Ethiopia: a cross-sectional study. BMC hematol 19(1):1–8CrossRef
41.
McKeever T, Sweeney MR, Staines A (2006) An investigation of the impact of prolonged waiting times on blood donors in Ireland. Vox Sang 90:113–118PubMedCrossRef
42.
Harrington M, Sweeney MR, Bailie K et al (2007) What would encourage blood donation in Ireland? Vox Sang 92:361–367PubMed
43.
Thomson RA, Bethel J, Lo AY et al (1998) Retention of “safe” blood donors. Retrovir Epidemiol Donor Study Transfus 38:359–367
44.
Shaz BH, James AB, Hillyer KL et al (2010) Demographic variations in blood donor deferrals in a major metropolitan area. Transfusion 50:881–887PubMedCrossRef
45.
Waller D, Thijsen A, Garradd A et al (2017) Donating blood for research: a potential method for enhancing customer satisfaction of permanently deferred blood donors. Blood Transfus 15:13–19PubMedPubMedCentral
46.
Spekman MLC, Ramondt S, Sweegers MG (2021) Whole blood donor behavior and availability after deferral: consequences of a new ferritin monitoring policy. Transfusion 61:1112–1121PubMedCrossRef
47.
Arcot PJ, Kumar K, Mukhopadhyay T et al (2020) Potential challenges faced by blood bank services during COVID-19 pandemic and their mitigative measures: The Indian scenario. Transfus Apher Sci 59:102877PubMedPubMedCentralCrossRef
48.
49.
Second Interim National Guidance to Blood Transfusion services in India in light of COVID-19 pandemic. National Blood Transfusion Council, MoHFW, GoI. 2020. Available at: www.​mohfw.​gov.​in. [Last accessed on 20th May 2021]
50.
Gemelli CN, Thijsen A, Van Dyke N et al (2018) Emotions experienced when receiving a temporary deferral: perspectives from staff and donors. ISBT Sci Ser 13:394–404CrossRef
51.
Unnikrishnan B, Rao P, Kumar N et al (2011) Profile of blood donors and reasons for deferral in coastal South India. Australia Med J 4:379–385CrossRef
52.
Gemelli CN, Kruse SP, Thijsen A et al (2019) Increasing the return of deferred donors: a reminder message for donors reaching the end of their deferral period. Vox Sang 114:92
53.
Walz E, McMullen D, Simpson L (1985) The recruitment of donors who have been temporarily deferred for upper respiratory infection or low hematocrit. Transfusion 25:485
54.
Sinclair KS, Campbell TS, Carey PM et al (2010) An adapted post donation motivational. Interv Enhanc Blood Donor Retent Transf 50:1778–1786
55.
Yang JO, Bei CH, Liang HQ et al (2020) Effective methods for reactivating inactive blood donors: a stratified randomized controlled study. BMC Public Health 20:475CrossRef
56.
Charbonneau J, Clourtier MS, Carrier E (2016) Why do blood donors lapse or reduce their donation’s frequency? Transfus Med Rev 30:1–5PubMedCrossRef
57.
Godin G, Amireault S, Vezina-Im LA et al (2013) Implementation intentions intervention among temporarily deferred novice blood donors. Transfusion 53:1653–1660PubMedCrossRef
58.
Sachdev S, Singh L, Marwaha N et al (2016) First report of the impact on voluntary blood donation by the blood mobile from India. Asian J Transfus Sci 10:59–62PubMedPubMedCentralCrossRef
59.
Sachdev S, Singh L, Sharma RR et al (2017) A study on the effect of pre-donation salt loading on vasovagal reactions in young college going whole blood donors. Indian J Hematol Blood Transfus 33:592–597PubMedPubMedCentralCrossRef
60.
Kumar K, Sachdev S, Marwaha N et al (2019) Role of salt supplementation on vasovagal reactions in young whole blood donors. ISBT Sci Ser 15:253–260CrossRef
Metadaten
Titel
Reinduction of the Temporarily Deferred Donors for Laying the Foundation of Safe and Sustainable Blood Supplies: A Review in the Indian Context
verfasst von
Priyadarsini Jayachandran Arcot
Karan Kumar
Suchet Sachdev
Ratti Ram Sharma
Poonam Coshic
Publikationsdatum
10.01.2022
Verlag
Springer India
Erschienen in
Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2022
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-021-01516-8

Weitere Artikel der Ausgabe 3/2022

Indian Journal of Hematology and Blood Transfusion 3/2022 Zur Ausgabe

Short Communication

Predicting Significant Hyperbilirubinemia in ABO Incompatibility: Is Cord Direct Antiglobulin Test Useful?

Correspondence

Missed Diagnosis of α-Globin Gene Cluster Duplication in Prenatal Screening: Identified Incidentally by Invasive Testing

Short Communication

Experience of Nivolumab Prior to Autologous Stem Cell Transplant for Relapsed Refractory Hodgkin Lymphoma

Short Communication

Patients with Classical Hodgkin Lymphoma with Less Than 10.5 CD20-Positive Reed–Sternberg Cells in 10 High-Power Fields Have Better Prognosis

Original Article

Usefulness of Leucocyte Cell Population Data by Sysmex XN1000 Hematology Analyzer in Rapid Identification of Acute Leukemia

Correspondence

Risk of Transfusion-Transmitted Hepatitis E Virus: Correspondence

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise